• Skip to main content
  • Skip to primary sidebar
  • Home
  • News
  • Marketplace
  • Events
  • Education
  • Interviews
    • Career spotlight
  • Opinion
    • Professional Dilemmas
    • Patient perspective
  • PIPcast
  • Jobs

Pharmacy in Practice

EDX/20/1154
Date of prep: December 2020

Prescribing information and
adverse events reporting

For healthcare professionals only

New export restrictions aim to protect UK flu vaccination supply

3rd November 2020 by PIP editor Leave a Comment

 

The UK government has announced restrictions on the export of supplies of flu vaccines to protect supplies for UK patients, following a global spike in demand.

 

The restrictions, which will apply to the flu vaccines being used in the UK this winter, will stop the exporting of medicines placed on the market to be used in the UK, which could cause future supply issues. There is sufficient national supply of flu vaccine, with deliveries to providers continuing over the coming months.

 

The Department of Health and Social Care has taken this action in response to high demand for the flu vaccine from other countries to mitigate against the risk of these products being exported.

 

Secretary of State of Health and Social Care, Matt Hancock said:

 

“We will always act to ensure that the medicines and vaccines destined for UK patients are protected and get to those who need them.

 

“This action will protect our supply of flu vaccinations, as part of our plans to give 30 million the flu vaccine ahead of this unprecedented winter.

 

“The NHS flu vaccination programme is well underway and it’s vital that if you are eligible for a free NHS flu vaccine you get one from your GP or pharmacy.”

 

Alongside the flu vaccines, further updates have been made to the existing list of medicines restricted for export and hoarding, including the removal of some products.

 

Companies that export a medicine that is on the export restrictions list may face regulatory action from the Medicines and Healthcare products Regulatory Agency (MHRA).

 

This circular is being shared under the Open Government Copyright licence.

 

 

Share this:

  • Click to share on LinkedIn (Opens in new window)
  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)
  • Click to share on Telegram (Opens in new window)
  • Click to email this to a friend (Opens in new window)

Related

Next article  Medicines innovation centre a step closer

Filed Under: News Tagged With: Vaccines

About PIP editor

Pharmacy in Practice is a UK pharmacy publication with its roots in Scotland.

Reader Interactions

Begin the discussion right here Cancel reply

Primary Sidebar

Stay connected with us

  • E-mail
  • Facebook
  • Instagram
  • LinkedIn
  • Phone
  • Twitter

Your Pharmacy in Practice Prescription

Categories

Pharmacy in Practice member login

 
 
Forgot Password

Register for our upcoming live Q&A

https://www.youtube.com/watch?v=vVNhKJWCGFA

© 2021 · About Pharmacy In Practice · Site mantained by Mike

This site is for healthcare professionals, please confirm you are a healthcare professional to continue.

YES

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
Pharmacy In Practice uses cookies, by continuing to use this site we will assume you are ok with that Find out more.